Monash University
Australian women will have greater access to medical abortion care and more options for miscarriage care after the Therapeutic Goods Administration (TGA) approved two major changes to a commonly used abortion medication.
MS-2 Step (mifepristone and misoprostol) is now approved for medical abortion up to 10 weeks' gestation (up from 9 weeks) and, for the first time, is approved for the medical management of missed miscarriage up to 10 weeks.
The changes took effect today, although PBS subsidies have not yet been extended to cover the new uses.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
